Gout Therapeutic Market to Reach US$3820 Million by 2027 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Gout Therapeutic Market to Reach US$3820 Million by 2027

Description:

Gout Therapeutic Market by Drug Type (Colchicine, Antihyperuricemic Agents ((Urate-Lowering Drugs)), Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Response Modifiers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Forecast – PowerPoint PPT presentation

Number of Views:0
Date added: 17 February 2020
Slides: 8
Provided by: pharmahealth

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Gout Therapeutic Market to Reach US$3820 Million by 2027


1
Gout Therapeutic Market
Gout Therapeutic Market Segmentation by Drug
Type - Colchicine, Antihyperuricemic Agents,
Non-steroidal Anti-inflammatory Drugs,
Corticosteroids, Biologic Response Modifiers
Distribution Channel - Hospital Pharmacy, Retail
Pharmacy, Online Pharmacy, and Forecast, 2019 -
2027
2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Acronyms
Chapter 3 Research Methodology
Chapter 4 Executive Summary Gout Therapeutic Market
Chapter 5 Market Overview
Chapter 6 Market Dynamics
Chapter 7 Global Gout Therapeutics Market Analysis and Forecast, by Component
Chapter 8 Global Gout Therapeutics Market Analysis and Forecast, by Distribution Channel
Chapter 9 Global Gout Therapeutics Market Analysis and Forecast, by Region
Chapter 10 North America Gout Therapeutics Market Analysis and Forecast
Chapter 11 Europe Gout Therapeutics Market Analysis and Forecast
Chapter 12 Asia Pacific Gout Therapeutics Market Analysis and Forecast
Chapter 13 Latin America Gout Therapeutics Market Analysis and Forecast
Chapter 14 Middle East Africa Gout Therapeutics Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3

Gout Therapeutic Market - Snapshot
  • Gout is a type of inflammatory arthritis caused
    by small crystals of a chemical called uric acid
    that form in the joints.
  • Gout has both active and inactive periods. Active
    periods of gout are known as attacks and can
    vary in severity and length.
  • Rise in prevalence of gout arthritis across the
    globe is anticipated to boost the global gout
    therapeutics market during the forecast period.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Reports Highlights
  • The global gout therapeutics market is projected
    to reach US 3820 Mn by 2027, expanding at a CAGR
    of 8.3 from 2019 to 2027.
  • Promising drug pipeline and approvals to propel
    gout therapeutics market.
  • Increase in patient preference for biologics
    drives the demand for gout therapeutics.
  • Antihyperuricemic agents (urate-lowering drugs)
    to be highly attractive segment.

Request For Sample
2019 Transparency Market Research, All Rights
Reserved
6
Continue..
  • New product development and strategic alliances
    in international market.
  • Key trend among leading players - Takeda
    Pharmaceutical Company Limited, Teijin Pharma
    Limited., Novartis AG, Mylan N.V., and Horizon
    Pharma plc.
  • Asia Pacific to Exhibit Positive Growth Rate in
    Coming Years.
  • Product Development and Strategic Alliances are
    Key for Leading Market Players include names such
    as MERCK Co. Inc., Iroko Pharmaceutical LLC,
    Hikma Pharmaceuticals PLC

Request For Brochure
2019 Transparency Market Research, All Rights
Reserved
7
Contact
To know more about us, please visit our website
www.transparencymarketresearch.com For sales
queries or new topics email us on
sales_at_transparencymarketresearch.com
Thank You
2019 Transparency Market Research, All Rights
Reserved
About PowerShow.com